Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q15633917> ?p ?o }
Showing triples 1 to 25 of
25
with 100 triples per page.
- Q15633917 subject Q10090201.
- Q15633917 subject Q8297717.
- Q15633917 subject Q8431759.
- Q15633917 subject Q8802906.
- Q15633917 subject Q9013830.
- Q15633917 abstract "Alisertib (MLN8237) is an orally available selective aurora A kinase inhibitor developed by Takeda. It is currently being investigated as a treatment for relapsed or refractory peripheral T-cell lymphoma.".
- Q15633917 iupacName "4-{[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid".
- Q15633917 thumbnail Alisertib.svg?width=300.
- Q15633917 wikiPageWikiLink Q10090201.
- Q15633917 wikiPageWikiLink Q14905704.
- Q15633917 wikiPageWikiLink Q7168693.
- Q15633917 wikiPageWikiLink Q8297717.
- Q15633917 wikiPageWikiLink Q8431759.
- Q15633917 wikiPageWikiLink Q8802906.
- Q15633917 wikiPageWikiLink Q899133.
- Q15633917 wikiPageWikiLink Q9013830.
- Q15633917 iupacname "4".
- Q15633917 type ChemicalCompound.
- Q15633917 type ChemicalSubstance.
- Q15633917 type ChemicalObject.
- Q15633917 type Thing.
- Q15633917 type Q11173.
- Q15633917 comment "Alisertib (MLN8237) is an orally available selective aurora A kinase inhibitor developed by Takeda. It is currently being investigated as a treatment for relapsed or refractory peripheral T-cell lymphoma.".
- Q15633917 label "Alisertib".
- Q15633917 depiction Alisertib.svg.